Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,755,897
+$4,704,777 QoQ
Shares Held
50,226
+52.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#962
of 4,676 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $65,400,986 across 13 Drug Manufacturers - General names. JNJ ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,692 | $16,422,596 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
50,226 | $12,755,897 | |
| 3 | ABBV |
AbbVie Inc.
|
45,476 | $11,443,580 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,249 | $6,585,496 | |
| 5 | PFE |
Pfizer Inc
|
208,486 | $5,020,342 | |
| 6 | AMGN |
Amgen Inc
|
13,140 | $4,758,256 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,389 | $2,672,934 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
16,707 | $2,110,762 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,755,897 | 50,226 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $8,051,120 | 32,937 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,113,474 | 39,205 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,905,256 | 31,848 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,048,638 | 26,505 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,452,622 | 20,819 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,615,260 | 11,169 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,845,377 | 11,387 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,711,095 | 11,707 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,060,266 | 13,024 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,047,808 | 13,065 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,054,342 | 13,190 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,102,435 | 12,702 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,711,820 | 11,044 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,446,763 | 8,190 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,160,999 | 7,107 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,039,143 | 5,854 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $958,991 | 5,411 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $238,813 | 1,396 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $243,057 | 1,505 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $86,768 | 617 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $115,001 | 877 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||